Cognitive effects of long-term treatment with waking-hour subcutaneous apomorphine infusions in ...

@article{988744,
   author = {Kubíková, Radka and Tyrlík, Mojmír and Rektorová, Irena},
   article_number = {4},
   keywords = {Affective; Apomorphine; Cognitive; Dementia; Parkinson's disease},
   language = {eng},
   issn = {1210-7859},
   journal = {Ceska a Slovenska Neurologie a Neurochirurgie},
   title = {Cognitive effects of long-term treatment with waking-hour subcutaneous apomorphine infusions in patients with advanced Parkinson's disease},
   url = {http://www.csnn.eu/en/czech-slovak-neurology-article/cognitive-effects-of-long-term-treatment-with-waking-hour-subcutaneous-apomorphine-infusions-in-patients-with-adv-35795?confirm_rules=1},
   volume = {74},
   year = {2011}
}

TY  - JOUR
ID  - 988744
AU  - Kubíková, Radka - Tyrlík, Mojmír - Rektorová, Irena
PY  - 2011
TI  - Cognitive effects of long-term treatment with waking-hour subcutaneous apomorphine infusions in patients with advanced Parkinson's disease
JF  - Ceska a Slovenska Neurologie a Neurochirurgie
VL  - 74
IS  - 4
SP  - 463-466
EP  - 463-466
PB  - Czech Medical Association J.E. Purkyne
SN  - 12107859
KW  - Affective
KW  - Apomorphine
KW  - Cognitive
KW  - Dementia
KW  - Parkinson's disease
UR  - http://www.csnn.eu/en/czech-slovak-neurology-article/cognitive-effects-of-long-term-treatment-with-waking-hour-subcutaneous-apomorphine-infusions-in-patients-with-adv-35795?confirm_rules=1
L2  - http://www.csnn.eu/en/czech-slovak-neurology-article/cognitive-effects-of-long-term-treatment-with-waking-hour-subcutaneous-apomorphine-infusions-in-patients-with-adv-35795?confirm_rules=1
N2  - Aims: To determine whether long-term treatment with continuous subcutaneous apomorphine infusions (CSAI) is safe for patients with Parkinson's disease (PD) with a history of hallucinations and/or marked cognitive deficit. Methods: 12 PD patients (9 men, 3 women; age 71.8 +- 6 years) were given neuropsychological assessment prior to continuous administration of CSAI and fourteen months after it. Results: CSAI led to clinical improvement, at least minimal, in all subjects. However, the treatment led to statistically significant impairment in verbal fluency tasks, the Mattis dementia rating scale (MDRS) score and the attention and initiation subtests. No mood changes were detected. Conclusions: We observed significant impairment in "frontal-like" tasks after continuous treatment with CSAI in our PD patients with baseline cognitive impairment. Further longitudinal controlled studies are needed to assess the impact of both CSAI and PD progression. We suggest cautious selection of patients eligible for CSAI therapy with respect to their cognitive profiles and/or neuropsychiatric complications.
ER  - 

KUBÍKOVÁ, Radka, Mojmír TYRLÍK a Irena REKTOROVÁ. Cognitive effects of long-term treatment with waking-hour subcutaneous apomorphine infusions in patients with advanced Parkinson's disease. Online. \textit{Ceska a Slovenska Neurologie a Neurochirurgie}. Czech Medical Association J.E. Purkyne, 2011, roč.~74, č.~4, s.~463-466. ISSN~1210-7859. [citováno 2024-04-24]